Consistent with these findings, recent research reported that the plasma FGF23 concentration is a risk factor of diabetic nephropathy (DN) triggering a series of pathological changes in kidney, and a valuable and sensitive biomarker in several acute and chronic disorders [11–14]. This evidence concerns the gene FGF23 and diabetic kidney disease.